Profile Summary

Medical Qualification:

  • M.B.B.S., Govt. Medical College, University of Nagpur

  • M.D. (Internal Medicine), Govt. Medical College, Nagpur

  • Training in Evidence-Based Diabetes Management, Public Health Foundation, India

  • Postgraduate Diploma in Medical Law & Ethics, NLSIU, Bangalore

Designation: Consultant & Head of Department, General Medicine

Years of experience: 35 years

Areas of expertise:

  • Internal Medicine
  • Diabetes care and prevention
  • Hypertension management
  • Medical ethics and evidence-based practice
  • Patient and public health education

Introduction:

Dr. (Mrs.) Anjali R. Kulkarni is a senior clinician in Internal Medicine with over three decades of dedicated service in clinical practice, teaching, and research. She has consistently made significant contributions to the advancement of internal medicine through her clinical acumen, leadership roles, and dedication to medical education. With a strong focus on diabetes prevention and the management of chronic conditions, Dr. Kulkarni brings a holistic and evidence-based approach to patient care. She is also actively involved in postgraduate training and guiding research scholars, reflecting her passion for academic excellence.

Awards & Publications:

Awards & Publications:

  • Numerous publications and presentations in national and international medical journals and conferences
  • Authored diabetes awareness booklets in multiple languages
  • Regular contributor of medical articles in reputed newspapers and magazines for public awareness
  • Risk of diabetes and expected years in life without diabetes among adults from an urban community in India: findings from a retrospective cohort: Palak Sharma, T.R. Dilip, Anjali Kulkarni, Udaya Shankar Mishra & Yogesh Shejul:BMC Public Health volume 24, Article number: 1048 (2024)
  • The lifetime risk of developing type II diabetes in an urban community in Mumbai: findings from a ten-year retrospective cohort study: Palak Sharma, T. R. Dilip, Udaya Shankar Mishra, Anjali Kulkarni : BMC Public Health volume 23, Article number: 1673 (2023)
  • Experiences of Covid-19 Early Vaccination: A Survey-Based Study from the Community Healthcare Setup in India: Rohan Jadhav, Laiby R, Anjali Kulkarni, Beena N, Lavanya S, Prashant B: International Journal of Medicine and Public Health June 2023,13(1):37-41
  • Improvement in estimates of GFR by using fat-free mass as compared to body weight in Indians: pilot study: Anjali Kulkarni, C S Yajnik, S Lavanya: medRxiv: 10.1101/2023.05.25.23289723 
  • Progression and management of diabetes in Indian settings with universal access to health care: Protocol for CHIPS cohort study Anjali Kulkarni, TR Dilip, Yogesh S, Prashant B, Puja G Palak Sharma KS James: https://medrxiv.org/cgi/content/short/2023.01.24.23284975v1
  • Comparison of Body Composition by Indigenously Developed Bioelectrical Impedance Analysis to Conventional Device and DEXA in Adults with Type 2 Diabetes Mellitus: Shweta Sharma, Anjali Kulkarni, Ashwini K: MAPCON, Pune, 2022
  • Acute onset breathlessness after a radiological procedure. Neth J Med. 2016 May;74(4):171.Shejul YK, Pendse, Kulkarni AR 
  • Fibromuscular dysplasia: a cause of secondary hypertension. Shejul Y, Viswanathan MK, Jangale P,  Kulkarni A Korean J Intern Med. 2014 Nov;29(6):840-1.
  • Evaluation of in vivo myocardial glucose kinetics in uncontrolled diabetes using FDG-PET. Kand PG, Nair N, Nayak U, Kulkarni A. World Federation of Nuclear Medicine & Biology 2006.
  • Role of Insulin in the Treatment of Acute Myocardial Infarction Bachwani AS, Kulkarni AR, Thakkar MG, Patel SJ. Abstract). Chest 2004; 126:8255.

Memberships:

Memberships:

  • Association of Physicians of India (API)
  • Research Society for the Study of Diabetes in India (RSSDI)
  • Indian Medical Association (IMA)
  • Society for Prevention of Hypertension and Diabetes (SPHD)